54 related articles for article (PubMed ID: 23267152)
1. Repeat re-irradiation with interstitial HDR-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.
Kim JK; Hardy-Abeloos C; Purswani JM; Kamen E; Concert CM; Duckworth T; Tam M; Haas J; Rybstein M; Vaezi A; Jacobson A; Hu KS
Brachytherapy; 2023; 22(4):503-511. PubMed ID: 36593130
[TBL] [Abstract][Full Text] [Related]
2. Salvage re-irradiation in non-melanoma skin cancers: A multicenter analysis.
Miszczyk M; Suleja A; Sobel S; Stec M; Chyrek AJ; Kolbusz M; Spałek M; Nasiek A; Stankiewicz M; Lelek P; Moll M; Kluska A; Kazalski D; Saniewski P; Kaminiów K; Burchardt WM; Wojcieszek P; Chicheł A; Cichoń P; Krzysztofiak T
Radiother Oncol; 2023 Dec; 189():109945. PubMed ID: 37806558
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinomas of the head and neck.
Sanderson RJ; Ironside JA
BMJ; 2002 Oct; 325(7368):822-7. PubMed ID: 12376446
[No Abstract] [Full Text] [Related]
4. The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer.
Kobayashi K; Tanaka Y; Horiguchi S; Yamamoto S; Toshinori N; Sugimoto A; Okamoto Y
Cancer Immunol Immunother; 2010 Oct; 59(10):1503-9. PubMed ID: 20582589
[TBL] [Abstract][Full Text] [Related]
5. B-ultrasound or CT-guided 3D-printing individualized non-coplanar template brachytherapy for the treatment of locally uncontrolled recurrent head and neck squamous cell carcinoma.
Han P; Li F; Zhang Y; Gao L; Zhang G; Guo Q; Zhu Y; Su Q
Postepy Dermatol Alergol; 2024 Feb; 41(1):41-48. PubMed ID: 38533370
[TBL] [Abstract][Full Text] [Related]
6. Radiobiological characterization of post-lumpectomy focal brachytherapy with lipid nanoparticle-carried radionuclides.
Hrycushko BA; Gutierrez AN; Goins B; Yan W; Phillips WT; Otto PM; Bao A
Phys Med Biol; 2011 Feb; 56(3):703-19. PubMed ID: 21299006
[TBL] [Abstract][Full Text] [Related]
7. Salvage High-Dose-Rate Interventional Radiotherapy (Brachytherapy) Combined with Surgery for Regionally Relapsed Head and Neck Cancers.
Soror T; Paul J; Melchert C; Idel C; Rades D; Bruchhage KL; Kovács G; Leichtle A
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760518
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of tumor recurrences or secondary carcinomas in pretreated area is not compatible with the primary therapy in non-previously treated tissue - an overview].
Dietz A; Wiegand S; Bläker H; Budach W
Laryngorhinootologie; 2023 Dec; 102(12):908-915. PubMed ID: 37696291
[TBL] [Abstract][Full Text] [Related]
9. Management of nasal vestibule carcinomas: recommendations by the Oncological Committee of the Italian Society of Otorhinolaryngology - Head and Neck Surgery.
Bussu F; Tagliaferri L; Corbisiero MF; Lotto C; Pellini R; Guarino P; Mercante G; Galuppi A; Cariti F; Almadori G; Longo F; Calabrese L; Galli J; Presutti L; Nicolai P; Molteni G
Acta Otorhinolaryngol Ital; 2024 Feb; 44(1):13-20. PubMed ID: 38420717
[TBL] [Abstract][Full Text] [Related]
10. Pilot Evaluation of Perioperative High Dose Rate Brachytherapy in Head Neck Cancers.
Bahl A; Panda NK; Verma RK; Sharma V; John JJ; Kumar P; Oinam AS; Trivedi G; Bakshi J
Indian J Otolaryngol Head Neck Surg; 2024 Apr; 76(2):2166-2170. PubMed ID: 38566724
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy.
Rudzianskas V; Inciura A; Juozaityte E; Rudzianskiene M; Kubilius R; Vaitkus S; Kaseta M; Adliene D
Acta Otorhinolaryngol Ital; 2012 Oct; 32(5):297-303. PubMed ID: 23326008
[TBL] [Abstract][Full Text] [Related]
12. Advancements of radiotherapy for recurrent head and neck cancer in modern era.
Zhang S; Zeng N; Yang J; He J; Zhu F; Liao W; Xiong M; Li Y
Radiat Oncol; 2023 Oct; 18(1):166. PubMed ID: 37803477
[TBL] [Abstract][Full Text] [Related]
13. Current radiotherapy for recurrent head and neck cancer in the modern era: a state-of-the-art review.
Li Y; Jiang Y; Qiu B; Sun H; Wang J
J Transl Med; 2022 Dec; 20(1):566. PubMed ID: 36474246
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery.
Rodin J; Bar-Ad V; Cognetti D; Curry J; Johnson J; Zender C; Doyle L; Kutler D; Leiby B; Keane W; Luginbuhl A
J Contemp Brachytherapy; 2018 Oct; 10(5):454-462. PubMed ID: 30479623
[TBL] [Abstract][Full Text] [Related]
15. Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases.
Teudt IU; Kovàcs G; Ritter M; Melchert C; Soror T; Wollenberg B; Meyer JE
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2707-15. PubMed ID: 26498949
[TBL] [Abstract][Full Text] [Related]
16. Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck.
Wiegand S; Sesterhenn AM; Zimmermann AP; Strassmann G; Wilhelm T; Werner JA
Anticancer Res; 2013 Jan; 33(1):249-52. PubMed ID: 23267152
[TBL] [Abstract][Full Text] [Related]
17. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
18. Combination of surgical resection and HDR-brachytherapy in patients with recurrent or advanced head and neck carcinomas.
Schiefke F; Hildebrandt G; Pohlmann S; Heinicke F; Hemprich A; Frerich B
J Craniomaxillofac Surg; 2008 Jul; 36(5):285-92. PubMed ID: 18353667
[TBL] [Abstract][Full Text] [Related]
19. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
Krüll A; Friedrich RE; Schwarz R; Thurmann H; Schmelzle R; Alberti W
Anticancer Res; 1999; 19(4A):2695-7. PubMed ID: 10470222
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
